Medtronic Gross Unrealized Gains decreased by 25.0% to $54.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 260.0%, from $15.00M to $54.00M. Over 4 years (FY 2021 to FY 2025), Gross Unrealized Gains shows a downward trend with a -36.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates favorable market conditions for the fixed-income portfolio, potentially boosting book value.
The total amount of unrealized gains on debt securities classified as available-for-sale that have not yet been recogniz...
Standard metric for insurance companies holding large bond portfolios.
other_available_for_sale_debt_securities_accumulated_gro_8d5dbc| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $155.00M | $162.00M | $111.00M | $59.00M | $5.00M | $5.00M | $1.00M | $7.00M | $6.00M | $5.00M | $4.00M | $14.00M | $7.00M | $18.00M | $22.00M | $15.00M | $26.00M | $33.00M | $72.00M | $54.00M |
| QoQ Change | — | +4.5% | -31.5% | -46.8% | -91.5% | +0.0% | -80.0% | +600.0% | -14.3% | -16.7% | -20.0% | +250.0% | -50.0% | +157.1% | +22.2% | -31.8% | +73.3% | +26.9% | +118.2% | -25.0% |
| YoY Change | — | — | — | — | -96.8% | -96.9% | -99.1% | -88.1% | +20.0% | +0.0% | +300.0% | +100.0% | +16.7% | +260.0% | +450.0% | +7.1% | +271.4% | +83.3% | +227.3% | +260.0% |